MedPath

Pryidostigmine Bromide

Pyridostigmine Bromide Oral Solution USP

Approved
Approval ID

0d642561-8ade-460b-b6b0-78cfc6cc2694

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 23, 2023

Manufacturers
FDA

Athem LLC

DUNS: 117077124

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pyridostigmine Bromide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code73152-028
Application NumberANDA208797
Product Classification
M
Marketing Category
C73584
G
Generic Name
Pyridostigmine Bromide
Product Specifications
Route of AdministrationORAL
Effective DateMarch 23, 2023
FDA Product Classification

INGREDIENTS (11)

ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
LACTIC ACIDInactive
Code: 33X04XA5AT
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
RASPBERRYInactive
Code: 4N14V5R27W
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
PYRIDOSTIGMINE BROMIDEActive
Quantity: 60 mg in 5 mL
Code: KVI301NA53
Classification: ACTIB
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pryidostigmine Bromide - FDA Drug Approval Details